Popular semaglutide-based drugs used for weight loss may reduce chronic and acute pain, which could make them a promising ...

Artemis Bayandor from Illinois in the US lost over a stone after starting to take game-changing weight-loss jabs, but like ...

It’s hard to remember a time before Ozempic, Wegovy, and other injectable drugs referred to as GLP-1 receptor agonists (that ...

A new study has revealed that GLP-1 drugs, commonly used for diabetes and weight loss, show promise in treating alcohol ...

Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

Ozempic and related GLP-1 drugs have taken Europe and North America by storm and have quickly become the darling of the ...

The United Kingdom will study whether the use of weight loss drugs could get people back to work. UK Health Minister Wes ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

The popular weight loss drugs have also been found to reduce other risks, including the risk of death from COVID-19.

A new study has shed light on the health risks faced by people who stop using weight-loss medications Ozempic or Wegovy.

In an essay for 'Women's Health,' Dr. Nora Volkow discusses the future of semaglutide weight-loss meds, and their potential ...